Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: An analysis of a randomized controlled trial

Pharmacogenetics and Genomics

Volumn 25, Issue 6, 2015, Pages 305-312

  Bress, Adam ^a   Kittles, Rick ^b   Wing, Coady ^c   Hooker, Stanley E ^d   King, Andrea ^e  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

African Americans; Ancestry; Naltrexone; Pharmacogenomics; Smoking cessation

Indexed keywords

NALTREXONE; PLACEBO;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; EUROPEAN AMERICAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; WEST AFRICAN; CAUCASIAN; GENETICS; GENOTYPE; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO USE DISORDER; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84929237797     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0000000000000138     Document Type: Article

References (63)

1. Agaku I, King B, Dube SR. Current cigarette smoking among adults - United States. MMWR Morb Mortal Wkly Rep 2011;61:889-894.
2. Moritsugu KP. The 2006 report of the surgeon general: the health consequences of involuntary exposure to tobacco smoke. Am J Prev Med 2007;32:542-543.
3. Trinidad DR, Perez-Stable EJ, Emery SL, White MM, Grana RA, Messer KS. Intermittent and light daily smoking across racial/ethnic groups in the United States. Nicotine Tob Res 2009;11:203-210.
4. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008;100:1672-1694.
5. Centers for Disease Control and Prevention (CDC). Racial/ethnic disparities and geographic differences in lung cancer incidence - 38 States and the District of Columbia, 1998-2006. MMWR Morb Mortal Wkly Rep 2010;59:1434-1438.
6. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013;5:CD009329.
7. Clark PI, Gautam S, Gerson LW. Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. Chest 1996;110:1194-1198.
8. Kabat GC, Morabia A, Wynder EL. Comparison of smoking habits of blacks and whites in a case-control study. Am J Public Health 1991;81:1483-1486.
9. Ishizawar D, Yancy C. Racial differences in heart failure therapeutics. Heart Fail Clin 2010;6:65-74.
10. ∗D. Med Care 2007;45:1043-1051.
11. Wood AJ. Racial differences in the response to drugs - pointers to genetic differences. N Engl J Med 2001;344:1394-1396.
12. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensinconverting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001;344:1351-1357.
13. Centers for Disease Control and Prevention (CDC). Racial disparities in smoking-attributable mortality and years of potential life lost - Missouri, 2003-2007. MMWR Morb Mortal Wkly Rep 2010;59:1518-1522.
14. O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, et al. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med 2006;166:667-674.
15. Byars JA, Frost-Pineda K, Jacobs WS, Gold MS. Naltrexone augments the effects of nicotine replacement therapy in female smokers. J Addict Dis 2005;24:49-60.
16. Covey LS, Glassman AH, Stetner F. Naltrexone effects on short-term and long-term smoking cessation. J Addict Dis 1999;18:31-40.
17. Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O'Malley SS. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. Drug Alcohol Depend 2010;111:200-206.
18. Wong GY, Wolter TD, Croghan GA, Croghan IT, Offord KP, Hurt RD. A randomized trial of naltrexone for smoking cessation. Addiction 1999;94:1227-1237.
19. Pomerleau OF. Endogenous opioids and smoking: a review of progress and problems. Psychoneuroendocrinology 1998;23:115-130.
20. Watkins SS, Koob GF, Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2000;2:19-37.
21. Ray LA, Oslin DW. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study. Drug Alcohol Depend 2009;105:256-258.
22. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295:2003-2017.
23. Chamorro AJ, Marcos M, Miron-Canelo JA, Pastor I, Gonzalez-Sarmiento R, Laso FJ. Association of μ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. Addict Biol 2012;17:505-512.
24. Chen AC, Morgenstern J, Davis CM, Kuerbis AN, Covault J, Kranzler HR. Variation in mu-opioid receptor gene (OPRM1) as a moderator of naltrexone treatment to reduce heavy drinking in a high functioning cohort. J Alcohol Drug Depend 2013;1:101.
25. Oroszi G, Anton RF, O'Malley S, Swift R, Pettinati H, Couper D, et al. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotypebased approach. Alcohol Clin Exp Res 2009;33:383-393.
26. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 2008;65:135-144.
27. Choudhry S, Coyle NE, Tang H, Salari K, Lind D, Clark SL, et al. Population stratification confounds genetic association studies among Latinos. Hum Genet 2006;118:652-664.
28. Kittles RA, Weiss KM. Race, ancestry, and genes: implications for defining disease risk. Annu Rev Genomics Hum Genet 2003;4:33-67.
29. Shriver MD, Kittles RA. Genetic ancestry and the search for personalized genetic histories. Nat Rev Genet 2004;5:611-618.
30. Bonilla C, Boxill LA, Donald SA, Williams T, Sylvester N, Parra EJ, et al. The 8818G allele of the agouti signaling protein (ASIP) gene is ancestral and is associated with darker skin color in African Americans. Hum Genet 2005;116:402-406.
31. Caulfield T, Fullerton SM, Ali-Khan SE, Arbour L, Burchard EG, Cooper RS, et al. Race and ancestry in biomedical research: exploring the challenges. Genome Med 2009;1:8.
32. Shriver MD, Parra EJ, Dios S, Bonilla C, Norton H, Jovel C, et al. Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet 2003;112:387-399.
33. Tsai HJ, Choudhry S, Naqvi M, Rodriguez-Cintron W, Burchard EG, Ziv E. Comparison of three methods to estimate genetic ancestry and control for stratification in genetic association studies among admixed populations. Hum Genet 2005;118:424-433.
34. Giri VN, Egleston B, Ruth K, Uzzo RG, Chen DY, Buyyounouski M, et al. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila) 2009;2:244-250.
35. Fejerman L, John EM, Huntsman S, Beckman K, Choudhry S, Perez-Stable E, et al. Genetic ancestry and risk of breast cancer among US Latinas. Cancer Res 2008;68:9723-9728.
36. Bress A, Han J, Patel SR, Desai AA, Mansour I, Groo V, et al. Association of aldosterone synthase polymorphism (CYP11B2-344 T >C) and genetic ancestry with atrial fibrillation and serum aldosterone in African Americans with heart failure. PLoS One 2013;8:e71268.
37. Bress A, Patel SR, Perera MA, Campbell RT, Kittles RA, Cavallari LH. Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans. Pharmacogenomics 2012;13:1925-1935.
38. King AC, Cao D, O'Malley SS, Kranzler HR, Cai X, deWit H, et al. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotinedependent men and women. J Clin Psychopharmacol 2012;32:630-636.
39. Krishnan-Sarin S, Rosen MI, O'Malley SS. Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence. Arch Gen Psychiatry 1999;56:663-668.
40. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003;5:13-25.
41. Al-Alem U, Rauscher G, Shah E, Batai K, Mahmoud A, Beisner E, et al. Association of genetic ancestry with breast cancer in ethnically diverse women from Chicago. PLoS One 2014;9:e112916.
42. Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G, et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 2009;30:69-78.
43. Nassir R, Kosoy R, Tian C, White PA, Butler LM, Silva G, et al. An ancestry informative marker set for determining continental origin: validation and extension using human genome diversity panels. BMC Genet 2009;10:39.
44. Torres JB, Stone AC, Kittles R. An anthropological genetic perspective on creolization in the Anglophone Caribbean. Am J Phys Anthropol 2013;151:135-143.
45. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003;164:1567-1587.
46. Hollingshead AdB. Four factor index of social status: Yale University. New Haven, CT: Department of Sociology; 1976. p. 22.
47. Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health 2007;97:1503-1509.
48. Efron B, Tibshirani R. An introduction to the bootstrap. New York: Chapman & Hall; 1993. p. 436.
49. Ray LA, Hutchison KE. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 2004;28:1789-1795.
50. Arias A, Feinn R, Kranzler HR. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 2006;83:262-268.
51. Coller JK, Beardsley J, Bignold J, Li Y, Merg F, Sullivan T, et al. Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: a meta-analysis. Pharmgenomics Pers Med 2009;2:9-19.
52. Corvol H, De Giacomo A, Eng C, Seibold M, Ziv E, Chapela R, et al. Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma. Pharmacogenet Genomics 2009;19:489-496.
53. Murphy E, Hou L, Maher BS, Woldehawariat G, Kassem L, Akula N, et al. Race, genetic ancestry and response to antidepressant treatment for major depression. Neuropsychopharmacology 2013;38:2598-2606.
54. Kumar R, Seibold MA, Aldrich MC, Williams LK, Reiner AP, Colangelo L, et al. Genetic ancestry in lung-function predictions. N Engl J Med 2010;363:321-330.
55. Huen K, Harley K, Beckman K, Eskenazi B, Holland N. Associations of PON1 and genetic ancestry with obesity in early childhood. PLoS One 2013;8:e62565.
56. Richman IB, Taylor KE, Chung SA, Trupin L, Petri M, Yelin E, et al. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum 2012;64:3374-3382.
57. Rumpel JA, Ahmedani BK, Peterson EL, Wells KE, Yang M, Levin AM, et al. Genetic ancestry and its association with asthma exacerbations among African American subjects with asthma. J Allergy Clin Immunol 2012;130:1302-1306.
58. Powell R, Davidson D, Divers J, Manichaikul A, Carr JJ, Detrano R, et al. Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study. Thorax 2013;68:634-642.
59. Berube JC, Lamontagne M, Couture C, Nickle D, Timens W, Postma DS, et al. Genome-wide genetic ancestry measurements to predict lung function in European populations. Eur Respir J 2013;42:1144-1147.
60. Sanchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD, et al. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum 2012;64:3687-3694.
61. Wise LA, Palmer JR, Ruiz-Narvaez E, Reich DE, Rosenberg L. Is the observed association between dairy intake and fibroids in African Americans explained by genetic ancestry? Am J Epidemiol 2013;178:1114-1119.
62. Fejerman L, Hu D, Huntsman S, John EM, Stern MC, Haiman CA, et al. Genetic ancestry and risk of mortality among US Latinas with breast cancer. Cancer Res 2013;73:7243-7253.
63. Fejerman L, Stern MC, Ziv E, John EM, Torres-Mejia G, Hines LM, et al. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women. Carcinogenesis 2013;34:1787-1793.